Global Antibodies Contract Manufacturing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 248340
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Services
Buy @ $3500

The Antibodies Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Antibodies Contract Manufacturing size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Antibodies Contract Manufacturing market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Antibodies Contract Manufacturing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monoclonal Antibodies

Antibody Fragments

Polyclonal Antibodies

Market segment by Application, can be divided into

SME

Large Enterprise

Market segment by players, this report covers

AMRI

AGC Biologics

Aldevron

Eurofins CDMO

Boehringer Ingelheim BioXcellence

FUJIFILM Diosynth Biotechnologies

Emergent BioSolutions

KBI Biopharma

Lonza

Novasep

Nitto Avecia Pharma Services

Pierre Fabre

Samsung BioLogics

Synthon

Thermo Fisher Scientific

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Antibodies Contract Manufacturing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Antibodies Contract Manufacturing, with revenue, gross margin and global market share of Antibodies Contract Manufacturing from 2019 to 2021.

Chapter 3, the Antibodies Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Antibodies Contract Manufacturing market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Antibodies Contract Manufacturing research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Antibodies Contract Manufacturing

1.2 Classification of Antibodies Contract Manufacturing by Type

1.2.1 Overview: Global Antibodies Contract Manufacturing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Antibodies Contract Manufacturing Revenue Market Share by Type in 2020

1.2.3 Monoclonal Antibodies

1.2.4 Antibody Fragments

1.2.5 Polyclonal Antibodies

1.3 Global Antibodies Contract Manufacturing Market by Application

1.3.1 Overview: Global Antibodies Contract Manufacturing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 SME

1.3.3 Large Enterprise

1.4 Global Antibodies Contract Manufacturing Market Size & Forecast

1.5 Global Antibodies Contract Manufacturing Market Size and Forecast by Region

1.5.1 Global Antibodies Contract Manufacturing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Antibodies Contract Manufacturing Market Size by Region, (2016-2021)

1.5.3 North America Antibodies Contract Manufacturing Market Size and Prospect (2016-2026)

1.5.4 Europe Antibodies Contract Manufacturing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Antibodies Contract Manufacturing Market Size and Prospect (2016-2026)

1.5.6 South America Antibodies Contract Manufacturing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Antibodies Contract Manufacturing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Antibodies Contract Manufacturing Market Drivers

1.6.2 Antibodies Contract Manufacturing Market Restraints

1.6.3 Antibodies Contract Manufacturing Trends Analysis

2 Company Profiles

2.1 AMRI

2.1.1 AMRI Details

2.1.2 AMRI Major Business

2.1.3 AMRI Antibodies Contract Manufacturing Product and Solutions

2.1.4 AMRI Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AMRI Recent Developments and Future Plans

2.2 AGC Biologics

2.2.1 AGC Biologics Details

2.2.2 AGC Biologics Major Business

2.2.3 AGC Biologics Antibodies Contract Manufacturing Product and Solutions

2.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 AGC Biologics Recent Developments and Future Plans

2.3 Aldevron

2.3.1 Aldevron Details

2.3.2 Aldevron Major Business

2.3.3 Aldevron Antibodies Contract Manufacturing Product and Solutions

2.3.4 Aldevron Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Aldevron Recent Developments and Future Plans

2.4 Eurofins CDMO

2.4.1 Eurofins CDMO Details

2.4.2 Eurofins CDMO Major Business

2.4.3 Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions

2.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Eurofins CDMO Recent Developments and Future Plans

2.5 Boehringer Ingelheim BioXcellence

2.5.1 Boehringer Ingelheim BioXcellence Details

2.5.2 Boehringer Ingelheim BioXcellence Major Business

2.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions

2.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans

2.6 FUJIFILM Diosynth Biotechnologies

2.6.1 FUJIFILM Diosynth Biotechnologies Details

2.6.2 FUJIFILM Diosynth Biotechnologies Major Business

2.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions

2.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

2.7 Emergent BioSolutions

2.7.1 Emergent BioSolutions Details

2.7.2 Emergent BioSolutions Major Business

2.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions

2.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Emergent BioSolutions Recent Developments and Future Plans

2.8 KBI Biopharma

2.8.1 KBI Biopharma Details

2.8.2 KBI Biopharma Major Business

2.8.3 KBI Biopharma Antibodies Contract Manufacturing Product and Solutions

2.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 KBI Biopharma Recent Developments and Future Plans

2.9 Lonza

2.9.1 Lonza Details

2.9.2 Lonza Major Business

2.9.3 Lonza Antibodies Contract Manufacturing Product and Solutions

2.9.4 Lonza Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Lonza Recent Developments and Future Plans

2.10 Novasep

2.10.1 Novasep Details

2.10.2 Novasep Major Business

2.10.3 Novasep Antibodies Contract Manufacturing Product and Solutions

2.10.4 Novasep Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Novasep Recent Developments and Future Plans

2.11 Nitto Avecia Pharma Services

2.11.1 Nitto Avecia Pharma Services Details

2.11.2 Nitto Avecia Pharma Services Major Business

2.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions

2.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Nitto Avecia Pharma Services Recent Developments and Future Plans

2.12 Pierre Fabre

2.12.1 Pierre Fabre Details

2.12.2 Pierre Fabre Major Business

2.12.3 Pierre Fabre Antibodies Contract Manufacturing Product and Solutions

2.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Pierre Fabre Recent Developments and Future Plans

2.13 Samsung BioLogics

2.13.1 Samsung BioLogics Details

2.13.2 Samsung BioLogics Major Business

2.13.3 Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions

2.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Samsung BioLogics Recent Developments and Future Plans

2.14 Synthon

2.14.1 Synthon Details

2.14.2 Synthon Major Business

2.14.3 Synthon Antibodies Contract Manufacturing Product and Solutions

2.14.4 Synthon Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Synthon Recent Developments and Future Plans

2.15 Thermo Fisher Scientific

2.15.1 Thermo Fisher Scientific Details

2.15.2 Thermo Fisher Scientific Major Business

2.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions

2.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Antibodies Contract Manufacturing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Antibodies Contract Manufacturing Players Market Share

3.2.2 Top 10 Antibodies Contract Manufacturing Players Market Share

3.2.3 Market Competition Trend

3.3 Antibodies Contract Manufacturing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Antibodies Contract Manufacturing Revenue and Market Share by Type (2016-2021)

4.2 Global Antibodies Contract Manufacturing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Antibodies Contract Manufacturing Revenue Market Share by Application (2016-2021)

5.2 Antibodies Contract Manufacturing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Antibodies Contract Manufacturing Revenue by Type (2016-2026)

6.2 North America Antibodies Contract Manufacturing Revenue by Application (2016-2026)

6.3 North America Antibodies Contract Manufacturing Market Size by Country

6.3.1 North America Antibodies Contract Manufacturing Revenue by Country (2016-2026)

6.3.2 United States Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

6.3.3 Canada Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

6.3.4 Mexico Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Antibodies Contract Manufacturing Revenue by Type (2016-2026)

7.2 Europe Antibodies Contract Manufacturing Revenue by Application (2016-2026)

7.3 Europe Antibodies Contract Manufacturing Market Size by Country

7.3.1 Europe Antibodies Contract Manufacturing Revenue by Country (2016-2026)

7.3.2 Germany Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

7.3.3 France Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

7.3.5 Russia Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

7.3.6 Italy Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Antibodies Contract Manufacturing Revenue by Type (2016-2026)

8.2 Asia-Pacific Antibodies Contract Manufacturing Revenue by Application (2016-2026)

8.3 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region

8.3.1 Asia-Pacific Antibodies Contract Manufacturing Revenue by Region (2016-2026)

8.3.2 China Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8.3.3 Japan Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8.3.4 South Korea Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8.3.5 India Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

8.3.7 Australia Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Antibodies Contract Manufacturing Revenue by Type (2016-2026)

9.2 South America Antibodies Contract Manufacturing Revenue by Application (2016-2026)

9.3 South America Antibodies Contract Manufacturing Market Size by Country

9.3.1 South America Antibodies Contract Manufacturing Revenue by Country (2016-2026)

9.3.2 Brazil Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

9.3.3 Argentina Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Antibodies Contract Manufacturing Revenue by Type (2016-2026)

10.2 Middle East & Africa Antibodies Contract Manufacturing Revenue by Application (2016-2026)

10.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country

10.3.1 Middle East & Africa Antibodies Contract Manufacturing Revenue by Country (2016-2026)

10.3.2 Turkey Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

10.3.4 UAE Antibodies Contract Manufacturing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Antibodies Contract Manufacturing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Antibodies Contract Manufacturing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Antibodies Contract Manufacturing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Antibodies Contract Manufacturing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Antibodies Contract Manufacturing Revenue Market Share by Region (2021-2026)

Table 6. AMRI Corporate Information, Head Office, and Major Competitors

Table 7. AMRI Major Business

Table 8. AMRI Antibodies Contract Manufacturing Product and Solutions

Table 9. AMRI Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. AGC Biologics Corporate Information, Head Office, and Major Competitors

Table 11. AGC Biologics Major Business

Table 12. AGC Biologics Antibodies Contract Manufacturing Product and Solutions

Table 13. AGC Biologics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Aldevron Corporate Information, Head Office, and Major Competitors

Table 15. Aldevron Major Business

Table 16. Aldevron Antibodies Contract Manufacturing Product and Solutions

Table 17. Aldevron Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Eurofins CDMO Corporate Information, Head Office, and Major Competitors

Table 19. Eurofins CDMO Major Business

Table 20. Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions

Table 21. Eurofins CDMO Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Boehringer Ingelheim BioXcellence Corporate Information, Head Office, and Major Competitors

Table 23. Boehringer Ingelheim BioXcellence Major Business

Table 24. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions

Table 25. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. FUJIFILM Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 27. FUJIFILM Diosynth Biotechnologies Major Business

Table 28. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions

Table 29. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Emergent BioSolutions Corporate Information, Head Office, and Major Competitors

Table 31. Emergent BioSolutions Major Business

Table 32. Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions

Table 33. Emergent BioSolutions Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. KBI Biopharma Corporate Information, Head Office, and Major Competitors

Table 35. KBI Biopharma Major Business

Table 36. KBI Biopharma Antibodies Contract Manufacturing Product and Solutions

Table 37. KBI Biopharma Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Lonza Corporate Information, Head Office, and Major Competitors

Table 39. Lonza Major Business

Table 40. Lonza Antibodies Contract Manufacturing Product and Solutions

Table 41. Lonza Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Novasep Corporate Information, Head Office, and Major Competitors

Table 43. Novasep Major Business

Table 44. Novasep Antibodies Contract Manufacturing Product and Solutions

Table 45. Novasep Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Nitto Avecia Pharma Services Corporate Information, Head Office, and Major Competitors

Table 47. Nitto Avecia Pharma Services Major Business

Table 48. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions

Table 49. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Pierre Fabre Corporate Information, Head Office, and Major Competitors

Table 51. Pierre Fabre Major Business

Table 52. Pierre Fabre Antibodies Contract Manufacturing Product and Solutions

Table 53. Pierre Fabre Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Samsung BioLogics Corporate Information, Head Office, and Major Competitors

Table 55. Samsung BioLogics Major Business

Table 56. Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions

Table 57. Samsung BioLogics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Synthon Corporate Information, Head Office, and Major Competitors

Table 59. Synthon Major Business

Table 60. Synthon Antibodies Contract Manufacturing Product and Solutions

Table 61. Synthon Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 63. Thermo Fisher Scientific Major Business

Table 64. Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions

Table 65. Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Antibodies Contract Manufacturing Revenue (USD Million) by Players (2019-2021)

Table 67. Global Antibodies Contract Manufacturing Revenue Share by Players (2019-2021)

Table 68. Breakdown of Antibodies Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Antibodies Contract Manufacturing Players Head Office, Products and Services Provided

Table 70. Antibodies Contract Manufacturing Mergers & Acquisitions in the Past Five Years

Table 71. Antibodies Contract Manufacturing New Entrants and Expansion Plans

Table 72. Global Antibodies Contract Manufacturing Revenue (USD Million) by Type (2016-2021)

Table 73. Global Antibodies Contract Manufacturing Revenue Share by Type (2016-2021)

Table 74. Global Antibodies Contract Manufacturing Revenue Forecast by Type (2021-2026)

Table 75. Global Antibodies Contract Manufacturing Revenue by Application (2016-2021)

Table 76. Global Antibodies Contract Manufacturing Revenue Forecast by Application (2021-2026)

Table 77. North America Antibodies Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Antibodies Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Antibodies Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Antibodies Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Antibodies Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Antibodies Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Antibodies Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Antibodies Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Antibodies Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Antibodies Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Antibodies Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Antibodies Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Antibodies Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Antibodies Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Antibodies Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Antibodies Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Antibodies Contract Manufacturing Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Antibodies Contract Manufacturing Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Antibodies Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Antibodies Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Antibodies Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Antibodies Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Antibodies Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Antibodies Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Antibodies Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Antibodies Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Antibodies Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Antibodies Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Antibodies Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Antibodies Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Antibodies Contract Manufacturing Picture

Figure 2. Global Antibodies Contract Manufacturing Revenue Market Share by Type in 2020

Figure 3. Monoclonal Antibodies

Figure 4. Antibody Fragments

Figure 5. Polyclonal Antibodies

Figure 6. Antibodies Contract Manufacturing Revenue Market Share by Application in 2020

Figure 7. SME Picture

Figure 8. Large Enterprise Picture

Figure 9. Global Antibodies Contract Manufacturing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Antibodies Contract Manufacturing Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Antibodies Contract Manufacturing Revenue Market Share by Region (2016-2026)

Figure 12. Global Antibodies Contract Manufacturing Revenue Market Share by Region in 2020

Figure 13. North America Antibodies Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Antibodies Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Antibodies Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Antibodies Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Antibodies Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Antibodies Contract Manufacturing Market Drivers

Figure 19. Antibodies Contract Manufacturing Market Restraints

Figure 20. Antibodies Contract Manufacturing Market Trends

Figure 21. AMRI Recent Developments and Future Plans

Figure 22. AGC Biologics Recent Developments and Future Plans

Figure 23. Aldevron Recent Developments and Future Plans

Figure 24. Eurofins CDMO Recent Developments and Future Plans

Figure 25. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans

Figure 26. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

Figure 27. Emergent BioSolutions Recent Developments and Future Plans

Figure 28. KBI Biopharma Recent Developments and Future Plans

Figure 29. Lonza Recent Developments and Future Plans

Figure 30. Novasep Recent Developments and Future Plans

Figure 31. Nitto Avecia Pharma Services Recent Developments and Future Plans

Figure 32. Pierre Fabre Recent Developments and Future Plans

Figure 33. Samsung BioLogics Recent Developments and Future Plans

Figure 34. Synthon Recent Developments and Future Plans

Figure 35. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 36. Global Antibodies Contract Manufacturing Revenue Share by Players in 2020

Figure 37. Antibodies Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Antibodies Contract Manufacturing Revenue Market Share in 2020

Figure 39. Global Top 10 Players Antibodies Contract Manufacturing Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Antibodies Contract Manufacturing Revenue Share by Type in 2020

Figure 42. Global Antibodies Contract Manufacturing Market Share Forecast by Type (2021-2026)

Figure 43. Global Antibodies Contract Manufacturing Revenue Share by Application in 2020

Figure 44. Global Antibodies Contract Manufacturing Market Share Forecast by Application (2021-2026)

Figure 45. North America Antibodies Contract Manufacturing Sales Market Share by Type (2016-2026)

Figure 46. North America Antibodies Contract Manufacturing Sales Market Share by Application (2016-2026)

Figure 47. North America Antibodies Contract Manufacturing Revenue Market Share by Country (2016-2026)

Figure 48. United States Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Antibodies Contract Manufacturing Sales Market Share by Type (2016-2026)

Figure 52. Europe Antibodies Contract Manufacturing Sales Market Share by Application (2016-2026)

Figure 53. Europe Antibodies Contract Manufacturing Revenue Market Share by Country (2016-2026)

Figure 54. Germany Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Antibodies Contract Manufacturing Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Antibodies Contract Manufacturing Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Antibodies Contract Manufacturing Revenue Market Share by Region (2016-2026)

Figure 62. China Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Antibodies Contract Manufacturing Sales Market Share by Type (2016-2026)

Figure 69. South America Antibodies Contract Manufacturing Sales Market Share by Application (2016-2026)

Figure 70. South America Antibodies Contract Manufacturing Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Antibodies Contract Manufacturing Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Antibodies Contract Manufacturing Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Antibodies Contract Manufacturing Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Antibodies Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz